J Clin Invest. 2014 Jun;124(6):2299-306. doi: 10.1172/JCI72267. Epub 2014 Jun 2.
Fibrosis is a characteristic feature of all forms of chronic kidney disease. Deposition of pathological matrix in the interstitial space and within the walls of glomerular capillaries as well as the cellular processes resulting in this deposition are increasingly recognized as important factors amplifying kidney injury and accelerating nephron demise. Recent insights into the cellular and molecular mechanisms of fibrogenesis herald the promise of new therapies to slow kidney disease progression. This review focuses on new findings that enhance understanding of cellular and molecular mechanisms of fibrosis, the characteristics of myofibroblasts, their progenitors, and molecular pathways regulating both fibrogenesis and its resolution.
纤维化是所有慢性肾脏病的特征。在肾间质和肾小球毛细血管壁中病理性基质的沉积,以及导致这种沉积的细胞过程,被认为是加剧肾脏损伤和加速肾单位丧失的重要因素。最近对纤维化发生的细胞和分子机制的深入了解,预示着新疗法有可能减缓肾脏病的进展。这篇综述重点介绍了增强对纤维化的细胞和分子机制、肌成纤维细胞及其前体细胞的特征,以及调节纤维化及其消退的分子途径的理解的新发现。